Revaginal Gel: Clinical Study in the Treatment of Postmenopausal Vulvovaginal Symptoms
Vulvovaginal disorders are an extremely common and often underestimated condition, affecting approximately 50% of postmenopausal women. Symptoms such as vaginal dryness, itching, burning, pain during intercourse, and general discomfort significantly impair quality of life, impacting psychological well-being and intimate relationships.
In this context, Revaginal Gel emerges as an effective treatment for alleviating postmenopausal vulvovaginal symptoms, as confirmed by the results of our clinical study.
Objective of the Study: Assessing the Impact of Revaginal Gel on Intimate Well-being
Promoted by Gruppo FarmaImpresa, the primary goal of this clinical study was to evaluate the efficacy of this vaginal gel medical device using the Vulvovaginal Symptoms Questionnaire (VSQ). This standardized, validated tool is specifically designed to quantify the presence and impact of key symptoms such as itching, dryness, irritation, pain, and sexual difficulties in postmenopausal women.
Study Methodology
The research involved 20 patients, who completed the VSQ questionnaire in two phases:
- T0: Before starting treatment, to establish baseline symptom levels
- T1: After two weeks of continuous treatment with Revaginal Gel
Already after just two weeks of treatment, the results showed significant improvements across all evaluated parameters.
Improvement of Symptoms: VSQ Scores Before and After Treatment
The following chart illustrates the dramatic reduction in perceived symptoms after two weeks of application:
Figure: Reduction in VSQ Score from Baseline to Day 14
The mean score dropped from 3.75 to 1.00, a statistically significant decrease confirmed by a paired t-test (p < 0.001). These findings underscore the gel’s rapid efficacy in improving intimate comfort.
Emotional and Relational Impact
The benefits of Revaginal Gel extended well beyond physical relief:
- Emotions: The percentage of patients reporting no emotional symptoms increased from 65% to 95%
- Impact on daily life: Improved from 65% to 95%, reflecting greater comfort in daily activities
- Sexual life: Significant improvements were reported in desire, pain reduction, and reduced discomfort during intercourse
Just two weeks of regular use led to clear symptom relief and enhanced quality of life, with benefits reaching into the emotional and relational dimensions of patient well-being.
A Complete Solution for Women’s Intimate Health
Revaginal Gel stands as a valuable therapeutic option for women in the delicate postmenopausal phase, offering not only physical relief but a real recovery of comfort, serenity, and intimate well-being.
Looking for a B2B-ready or private label solution?
We are certified manufacturers of medical devices, dietary supplements, and cosmetics.
Revaginal Gel is ready for market entry or private labeling, with full regulatory and clinical support.
